Cyclo Therapeutics Provides Clinical Program Update and Highlights Recent Achievements Business Wire - Wed Jan 11, 7:05AM CST
Business Wire
Wed Jan 11, 7:05AM CST
Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases,...
JTC Team to Host the Virtual Investor 2023 Companies to Watch Event on January 17th, 18th, and 19th ACCESSWIRE - Wed Jan 11, 7:00AM CST
ACCESSWIRE
Wed Jan 11, 7:00AM CST
- Live video webcast presentations with participating companies -
Cyclo Therapeutics to Present at the Virtual Investor 2023 Companies to Watch Event Business Wire - Tue Jan 10, 7:05AM CST
Business Wire
Tue Jan 10, 7:05AM CST
Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases,...